Article: Abilify wins clearance.(RX: RETAIL PHARMACY: Branded Drugs)(FDA approves Abilify which is marketed by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Company Ltd.)(Brief article)

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  November 7, 2001 ;     700+ words ... ... these data, Bristol-Myers Squibb and Otsuka Pharmaceutical also expect to file ... About Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., are ...

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  December 27, 2006 ;     700+ words ... ... FirstCall/ -- Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today ... About Bristol-Myers Squibb Bristol-Myers Squibb is a global pharmaceutical ... human life. About Otsuka Pharmaceutical Co., Ltd. Founded ...

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  March 5, 2008 ;     700+ words ... ... a new report that finds that Bristol-Myers Squibb and Otsuka Pharmaceutical spend almost twice as much on Abilify ... and fewer than 10% mention Bristol- Myers Squibb or Otsuka Pharmaceutical as a top-of-mind company in atypical ...

Article: CytoDyn Shows U.S. Senate Field Rep That HIV/AIDS is Still a ...
M2 Presswire;  August 18, 2006 ;     700+ words ... ... a Serious Problem and Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating ... the Schering-Plough. Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. recently announced ...

Article: Bristol-Myers Squibb granted Otsuka ...
Medical Marketing & Media;  February 1, 2007 ;     604 words ...Bristol-Myers Squibb granted Otsuka Pharmaceutical the exclusive rights in Japan to develop and commercialize the investigational compound saxagliptin, which is being studied for ...

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  August 17, 2006 ;     700+ words ... ... Bipolar I Disorder PRINCETON, N.J. and TOKYO, Aug. 17 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY(R) DISCMELT(TM) (aripiprazole) Orally ...

Article: Abilify approval.(RXs)(Bristol-Myers Squibb ...
Chain Drug Review;  January 22, 2007 ;     700+ words ...Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. have debuted Abilify injection. The product is indicated for adults with agitation associated with schizophrenia or bipolar mania.